composite lymphoma (Cancer)
Information
- Disease name
- composite lymphoma
- Disease ID
- DOID:5820
- Description
- "A lymphoma that begins in cells of the immune system in which different types of lymphoma cells occur at the same time." [url:http\://www.cancer.gov/dictionary/?CdrID=633086]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02541565 | Completed | Phase 1 | Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma | November 24, 2015 | December 18, 2018 |
| NCT05025800 | Recruiting | Phase 1/Phase 2 | ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma | October 13, 2021 | March 10, 2026 |
- Disase is a (Disease Ontology)
- DOID:707
- Cross Reference ID (Disease Ontology)
- MESH:D058617
- Cross Reference ID (Disease Ontology)
- NCI:C38661
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:1156403002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0545080
- MeSH unique ID (MeSH (Medical Subject Headings))
- D058617